一种功能丧失的人类ADAR变种激活了先天免疫反应,并促进了肠道炎症
Pengfei Xu1,2,3, Yue Xi4, Jong-Won Kim4,5,6
1Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA, USA. pex9@pitt.edu.
减少RNA编辑酶ADAR (作用于RNA1的腺氨酸脱氨酶) 的表达,有助于炎症性肠病 (IBD). ADAR缺乏导致免疫系统激活,这表明ADAR-dsRNA/ERVs-MDA5-JAK/STAT轴作为IBD的治疗点.
科学领域:
- 胃肠道学和免疫学
- 在RNA生物学,RNA生物学.
- 分子医学是分子医学.
背景情况:
- 炎症性肠病 (IBD) 涉及复杂的遗传和环境因素.
- 作用于RNA 1 (ADAR) 的腺氨酸脱氨酶对于维持组织平衡至关重要.
- 在IBD患者的肠道密室中观察到ADAR表达的减少.
研究的目的:
- 为了研究ADAR在IBD病原发生中的作用.
- 阐明将ADAR缺乏与肠道炎症联系起来的分子机制.
- 为了确定IBD的潜在治疗点.
主要方法:
- 对人类IBD患者组织中ADAR表达的分析.
- 在小鼠模型中诱导ADAR缺乏,以研究大肠炎和大肠炎.
- 有机体研究,以评估ADAR损失对肠道平衡的影响.
- 编辑组分析以确定ADAR目标.
- 使用JAK1/2抑制剂Ruxolitinib的药理抑制.
主要成果:
- 人和小鼠的肠道ADAR缺乏导致IBD.
- ADAR损失导致双链RNA (dsRNA) 和内源逆转录病毒 (ERV) 的积累.
- 这种积累激活了MDA5介导的dsRNA传感和JAK/STAT信号.
- 编辑的Mda5显示dsrna感应受损,功能丧失的ADAR突变加剧IBD.
- 在小鼠模型中,ruxolitinib治疗减弱了IBD.
结论:
- ADAR-dsRNA/ERVs-MDA5-JAK/STAT信号轴与IBD病变发生有关.
- 针对这个轴,例如使用JAK抑制剂,可能为IBD提供治疗策略.
更多相关视频
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
09:08Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
相关概念视频
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
